The World Health Organization (WHO) on Monday issued a health advisory warning about three contaminated cough syrups identified in India and urged authorities to report any detections to the agency.
The health agency said the affected medicines are specific batches of COLDRIF, Respifresh TR and ReLife, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals and Shape Pharma.
The agency said the contaminated products pose significant risks and can cause severe, potentially life-threatening illness.
India's health authority, the Central Drugs Standard Control Organization (CDSCO), told WHO the syrups were reportedly consumed by 17 children under five who died in India last week.
CDSCO said none of the contaminated medicines have been exported from India and there is no evidence of illegal export.
The health agency said the affected medicines are specific batches of COLDRIF, Respifresh TR and ReLife, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals and Shape Pharma.
The agency said the contaminated products pose significant risks and can cause severe, potentially life-threatening illness.
India's health authority, the Central Drugs Standard Control Organization (CDSCO), told WHO the syrups were reportedly consumed by 17 children under five who died in India last week.
CDSCO said none of the contaminated medicines have been exported from India and there is no evidence of illegal export.
You may also like
'Regrettable': Norway on Venezuela embassy closure; move follows Nobel honour for opposition leader Maria Machado
Buddhist Compassion Relief Tzu Chi Foundation and BHU to establish research centre for Buddhism
Haryana DGP Shatrujeet Kapur sent on leave amid IPS Y Puran Kumar suicide case
Artha India Ventures Marks First Close Of INR 500 Cr Second Fund At INR 250 Cr
Diwali celebration away from home: Healthy twists on classic mithai
